Investor Information

News

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

View News

Summit Therapeutics to Present at Upcoming Investor Conferences

View News

More Information

Share Price

NASDAQ: SMMT

17.87 USD

20-Dec-2024 16:00 UTC-5

More Information

SEC Filings

Quarterly report pursuant to sections 13 or 15(d)

View News

Current report filing

View News

More Information

Email Alerts